INmune Bio has announced favorable results from its recent clinical trial focused on Alzheimer's disease, highlighting positive findings from MRI scans conducted on participants. The data suggests that the treatment may have beneficial effects on brain health in individuals affected by this neurodegenerative condition. These results are part of ongoing research efforts aimed at developing effective therapies for Alzheimer's disease. Further analysis and subsequent trials will be necessary to validate these findings and assess the long-term implications for treatment.
Related Articles
Don't miss out on breaking stories and in-depth articles.